tm
Seeing Is Believing
tm
Seeing Is Believing
ACAD is currently covered by 19 analysts with an average potential upside of $8.81 (36.01%) backed by displayed 204 price targets and 275 ratings.
Analysts average stock forecasts to be materialized ratio is 78.73% with an average time for these price targets to be met of 265.52 days.
Highest price target for ACAD is 32, Lowest price target is 13, average price target is 22.5.
Most recent stock forecast was given by JEFFREY HUNG from MORGAN STANLEY on 03-Aug-2023. First documented stock forecast 19-Mar-2013.
Currently, out of the existing stock ratings of ACAD - 64 which are a Hold (53.33%), 53 which are a Buy (44.17%), 3 which are a Sell (2.5%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Hold
30
$4.42 (17.28%)
30
1 months 25 days ago
14/20 (70%)
$6 (20.78%)
165
Buy
38
$12.42 (48.55%)
26
1 months 25 days ago
15/18 (83.33%)
$7.65 (27.96%)
182
Buy
33
$7.42 (29.01%)
33
1 months 25 days ago
9/13 (69.23%)
$8.33 (34.09%)
122
Hold
25
$-0.58 (-2.27%)
25
1 months 25 days ago
10/12 (83.33%)
$-0.47 (0.44%)
40
Buy
33
$7.42 (29.01%)
27
2 months 14 days ago
10/16 (62.5%)
$9.2 (38.05%)
224
What is ACAD (ACADIA Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on ACAD (ACADIA Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on ACAD (ACADIA Pharmaceuticals)?
Which analyst is the currently most bullish on ACAD (ACADIA Pharmaceuticals)?
Which analyst is the currently most reserved on ACAD (ACADIA Pharmaceuticals)?
